AnTolRx
Innovative therapies for autoimmune diseases through targeted immune-regulation using proprietary nanoparticle-based solutions.
est. 2015
Greywolf Therapeutics
We are advancing novel antigen modulation technology that controls T cells to guide the immune system.
49 employees · est. 2017 · United Kingdom
AnTolRx is the older company (2015 vs 2017).
Side-by-Side Comparison
| Metric | AnTolRx | Greywolf Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2015 older | 2017 |
| Headquarters | ||
| Headquarters | Not tracked yet | United Kingdom |
| Employees | ||
| Employees | Not tracked yet | 49 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Series B |
| Total Funding | ||
| Total Funding | $4.00M | $107.10M |
| Funding Rounds | ||
| Funding Rounds | 1 | 5 |
| Services | ||
| Services | Not tracked yet | Development of antigen modulation technology for therapeutic treatments in oncology, autoimmunity, and virology |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with cancers, autoimmune disorders, and infectious diseases |
| Taxonomy | ||
| Taxonomy | Nanoparticle-based Therapies, Autoimmune Diseases, Immune Regulation, Tolerogenic Signal, Drug Development, Antigen-specific Immune Tolerance, Precision Medicine, Innovative Therapies, Immunotherapy, Healthcare Innovation | Biotherapeutics, Immunotherapy, Cancer Treatment, Autoimmune Disorders, Infectious Diseases, T Cell Activation, Antigen Modulation, Clinical Development, Immunology, Therapeutic Innovations |
| Website | ||
| Website | antolrx.com | greywolftherapeutics.com |
About AnTolRx
AnTolRx is a biotechnology and healthcare startup founded in 2015, pioneering innovative therapies for autoimmune diseases. The company's slogan, "Innovative therapies for autoimmune diseases through targeted immune-regulation using proprietary nanoparticle-based solutions," encapsulates its mission...
About Greywolf Therapeutics
Greywolf Therapeutics is a biotechnology startup based in the United Kingdom, founded in 2017. The company is focused on solving immune dysfunction by advancing novel antigen modulation technology that guides the immune system. Their approach addresses the challenge of T cells not being able to reco...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at AnTolRx and Greywolf Therapeutics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at AnTolRx and Greywolf Therapeutics — by email.
Frequently Asked Questions
Compare AnTolRx with someone else
Start typing a company name or domain.